Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-25-001278
Filing Date
2025-02-14
Accepted
2025-02-14 17:25:54
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 8947
  Complete submission text file 0001172661-25-001278.txt   10754
Mailing Address 101 CRAWFORDS CORNER RD SUITE 4116 HOLMDEL NJ 07733
Business Address 101 CRAWFORDS CORNER RD SUITE 4116 HOLMDEL NJ 07733 7323591100
BIO KEY INTERNATIONAL INC (Subject) CIK: 0001019034 (see all company filings)

EIN.: 411761861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-78825 | Film No.: 25631131
SIC: 7372 Services-Prepackaged Software
(CF Office: 06 Technology)

Mailing Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022
Business Address 510 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A